Managing migraine by patient profile: role of frovatriptan

References

• LiptonRBDiamondSReedMDiamondMLStewartWFMigraine diagnosis and treatment: results from the American Migraine Study IIHeadache20014163864511554951
   PubMed Web of Science ®Google Scholar
• BelvísRPagonabarragaJKulisevskyJIndividual triptan selection in migraine attack therapyRecent Pat CNS Drug Discov200941708119149716
   PubMedGoogle Scholar
• CadyRKSchreiberCPFarmerKUUnderstanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headacheHeadache20044442643515147250
   PubMed Web of Science ®Google Scholar
• VianaMSancesGGhiottoNVariability of the characteristics of a migraine attack within patientsCephalalgia Epub20151023
   Google Scholar
• CadyRFarmerKDexterJKSchreiberCCosensitization of pain and psychiatric comorbidity in chronic daily headacheCurr Pain Headache Rep200591475215625025
   PubMedGoogle Scholar
• YunusMBCentral sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illnessSemin Arthritis Rheum200837633935218191990
   PubMed Web of Science ®Google Scholar
• DiamondSCadyRKDiamondMLGreenMWMartinVTHeadache and Migraine Biology and ManagementWaltham, MAAcademic Press2015
   Google Scholar
• CadyRKSchreiberCPSinus headache or migraine? Considerations in making a differential diagnosisNeurology2002589 Suppl 6S10S1412011268
   PubMed Web of Science ®Google Scholar
• KanieckiRGMigraine and tension-type headache: an assessment of challenges in diagnosisNeurology2002589 Suppl 6S15S2012011269
   PubMed Web of Science ®Google Scholar
• CadyRKLiptonRBRothrockJFChronic Migraine: A Patient-Centered Guide to Effective ManagementHamilton, ON, CanadaBaxter Publishing Inc2013
   Google Scholar
• LiptonRBBigalMEMigraine: Epidemiology, impact, and risk factors for progressionHeadache200545Suppl 1S3S1315833088
   PubMed Web of Science ®Google Scholar
• AshinaSLiptonRBBigalMETreatment of comorbidities of chronic daily headacheCurr Treat Options Neurol2008101364318325298
   PubMed Web of Science ®Google Scholar
• BuseDCManackASerranoDTurkelCLiptonRBSociodemographic and co morbidity profiles of chronic migraine and episodic migraine sufferersJ Neurol Neurosurg Psychiatry201081442843220164501
   PubMed Web of Science ®Google Scholar
• ScherAIStewartWFLiptonRBThe comorbidity of headache with other pain syndromesHeadache20064691416142317040338
   PubMed Web of Science ®Google Scholar
• NegroAD’AlonzoLMartellettiPChronic migraine: comorbidities, risk factors, and rehabilitationIntern Emerg Med20105Suppl 1S13S1920865469
   PubMed Web of Science ®Google Scholar
• SinghGRecent considerations in nonsteroidal anti-inflammatory drug gastropathyAm J Med19981051B31S38S9715832
   PubMedGoogle Scholar
• WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal anti-inflammatory drugsN Engl J Med1999340241888189910369853
   PubMed Web of Science ®Google Scholar
• SheftellFTepperSJNew paradigms in the recognition and acute treatment of migraineHeadache200242586912005277
   PubMed Web of Science ®Google Scholar
• LucianiRCarterDMannixLHemphillMDiamondMCadyRKPrevention of migraine during prodrome with naratriptanCephalalgia20002012212610961768
   PubMed Web of Science ®Google Scholar
• CadyRDodickDWDiagnosis and treatment of migraineMayo Clin Proc20027725526111888029
   PubMed Web of Science ®Google Scholar
• KelmanLThe triggers or precipitants of the acute migraine attackCephalalgia200727539440217403039
   PubMed Web of Science ®Google Scholar
• MartinVTBehbehaniMMToward a rational understanding of migraine trigger factorsMed Clin North Am20018591194111480265
   PubMed Web of Science ®Google Scholar
• BuseDCAndrasikFBehavioral medicine for migraineNeurol Clin200927244546519289225
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS)The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia201333609808
   Web of Science ®Google Scholar
• CadyRKSheftellFLiptonRBEarly treatment with sumatriptan enhances pain-free responses: retrospective analysis from three clinical trialsClin Ther20002291035104811048903
   PubMed Web of Science ®Google Scholar
• CarpayJSchoenenJAhmadFKinradeFBoswellDEfficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled studyClin Ther20042621422315038944
   PubMed Web of Science ®Google Scholar
• MathewNTFinlaysonGSmithTREarly intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study)Headache20074718919817300358
   PubMed Web of Science ®Google Scholar
• FoleyKACadyRKMartinVTreating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraineHeadache20054553855415953272
   PubMed Web of Science ®Google Scholar
• LiptonRBFanningKMSerranoDReedMLCadyRBuseDCIneffective acute treatment of episodic migraine is associated with new-onset chronic migraineNeurology201584768869525609757
   PubMed Web of Science ®Google Scholar
• SilbersteinSDPharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introductionHeadache200242Suppl 2S42S46
   Google Scholar
• BuchanPKeywoodCWadeAWardCClinical pharmacokinetics of frovatriptanHeadache200242Suppl 2S54S6212028321
   PubMed Web of Science ®Google Scholar
• GeraudGKeywoodCSenardJMMigraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptansHeadache20034337638812656709
   PubMed Web of Science ®Google Scholar
• RyanRGeraudGGoldstwinJCadyRKeywoodCClinical efficacy of frovatriptan: placebo-controlled studiesHeadache200242Suppl 2S84S9212028324
   PubMed Web of Science ®Google Scholar
• SaviLMogaveroSEganCGEfficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraineDrug Des Devel Ther20148983992
   PubMed Web of Science ®Google Scholar
• SanfordMFrovatriptan: a review of its use in the acute treatment of migraineCNS Drugs201226979181122900951
   PubMed Web of Science ®Google Scholar
• SpieringsELKeywoodCRapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label studyPain Med200910463363819453958
   PubMed Web of Science ®Google Scholar
• CadyRSchreiberCFrovatriptan: clinical review and future directionsFuture Neurol2006111319
   Google Scholar
• RapoportARyanRGoldsteinJKeywoodCDose range-finding studies with frovatriptan in the acute treatment of migraineHeadache200242Suppl 2S74S8312028323
   PubMed Web of Science ®Google Scholar
• ParsonsAARavalPSmithSEffects of novel high-affinity 5-HT-1B/1D receptor ligand frovatriptan in human isolated basilar and coronary arteriesJ Cardiovasc Pharmacol1998322202249700983
   PubMed Web of Science ®Google Scholar
• ParsonsAAValocikRKosterPEffects of the novel anti-migraine agent frovatriptan on coronary and cardiac function in dogsJ Cardiovasc Pharmacol1997301361419268233
   PubMed Web of Science ®Google Scholar
• GoldsteinJKeywoodCA lose dose finding study of frovatriptan (VML251) a potent cerebroselective 5-HT-1B/1D agonist for the acute treatment of migraine (abstract)Funct Neurol199813178
   Google Scholar
• GeraudGSpieringsELHKeywoodCTolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptanHeadache200242Suppl 2S93S9912028325
   PubMed Web of Science ®Google Scholar
• CadyRKKeywoodCFrovatriptan: preliminary efficacy in the early treatment of migraine attacksCephalalgia200121426 Abstract #P2-K48
   Google Scholar
• CadyRElkindAGoldsteinJKeywoodCRandomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severeCurr Med Res Opin2004201465147215383196
   PubMed Web of Science ®Google Scholar
• TulloVValguarneraFBarbantiPComparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized studyCephalalgia201434643444524363238
   PubMed Web of Science ®Google Scholar
• NewmanLCLiptonRBLayCLSolomonSA pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraineNeurology1998513073099674831
   PubMed Web of Science ®Google Scholar
• NewmanLCMannixLKLandySNaratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyHeadache20014124825611264684
   PubMed Web of Science ®Google Scholar
• SilbersteinSDElkindAHSchreiberCPKeywoodCA random-ized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology20046326126915277618
   PubMed Web of Science ®Google Scholar
• BrandesJLPooleAKallelaMShort-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacksCephalalgia200929111133114819811503
   PubMed Web of Science ®Google Scholar
• CadyRKVoirinJFarmerKBrowningRBeachMETarraschJTwo center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implicationsHeadache201252574976422188311
   PubMed Web of Science ®Google Scholar
• LisottoCLidia SaviLPinessiLEfficacy of frovatriptan vs other triptans in weekend migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studiesBrain Disord Ther201433128
   Google Scholar
• SaraccoMGAllaisGTulloVEfficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studiesNeurol Sci201435Suppl 111511924867847
   PubMed Web of Science ®Google Scholar
• TulloVBussoneGOmboniSEfficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studiesNeurol Sci201334Suppl 1S87S9123695053
   PubMed Web of Science ®Google Scholar